Skip to main content

Table 2 Relationship between Ki67 and PIK3CA mutation status a

From: Relationship of PIK3CA mutation and pathway activity with antiproliferative response to aromatase inhibition

  

WT/Mu

 

n

WT, median (IQR)

Mu, median (IQR)

P-value

Baseline Ki67

81

18.2 (56, 12.7 to 27.3)

12.5 (25, 5.7 to 21.0)

0.051

2-week Ki67

75

5.8 (52, 1.8 to 19.8)

3.1 (23, 1.0 to 7.2)

0.050

2-wk/pre-Ki67%

73

31.3 (50, 14.5 to 70.8)

23.1 (23, 11.6 to 44.2)

0.346

  1. aMu, Mutant; WT, Wild type.
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us